Description
2022 SUBCONTRACTING PLAN EFFECTIVE 01/01/2022 - 12/31/2022
Base award description: REPACKAGING AND DISTRIBUTION SERVICES
Modification chain · 14 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-03-01+$925,721= $925,721
- Mod P000012017-05-02+$0= $925,721
- Mod P000022018-01-11+$0= $925,721
- Mod A000032018-02-21+$0= $925,721
- Mod P000042019-01-11+$0= $925,721
- Mod P000052019-02-13+$0= $925,721
- Mod P000062019-03-18+$0= $925,721
- Mod P000072020-01-30+$0= $925,721
- Mod P000082020-02-11+$0= $925,721
- Mod P000092020-08-31+$0= $925,721
- Mod P000102021-01-04+$0= $925,721
- Mod P000112021-02-01+$0= $925,721
- Mod P000122021-12-13+$0= $925,721
- Mod P000132022-01-12+$0= $925,721
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-03-01 | +$925,721 | $925,721 | REPACKAGING AND DISTRIBUTION SERVICES |
| Mod P00001· ADD SUBCONTRACTING PLAN | 2017-05-02 | +$0 | $925,721 | INCORPORATE 2017 SUBKT PLAN |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2018-01-11 | +$0 | $925,721 | INCORPORATE 2018 SUBKT PLAN |
| Mod A00003· EXERCISE AN OPTION | 2018-02-21 | +$0 | $925,721 | EXERCISING OPTION YEAR ONE EFFECTIVE 03/01/2018 - 02/28/2019 |
| Mod P00004· ADD SUBCONTRACTING PLAN | 2019-01-11 | +$0 | $925,721 | INCORPORATE THE 2019 SUBCONTRACTING PLAN EFFECTIVE 01/01/2019 - 12/31/2019 |
| Mod P00005· EXERCISE AN OPTION | 2019-02-13 | +$0 | $925,721 | EXERCISING OPTION YEAR TWO EFFECTIVE 03/01/2019 - 02/29/2020 |
| Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-03-18 | +$0 | $925,721 | INCORPORATING ADDITIONAL PRODUCT REGISTRATION REQUIREMENTS. |
| Mod P00007· EXERCISE AN OPTION | 2020-01-30 | +$0 | $925,721 | EXERCISE OPTION TO EXTEND PERFORMANCE PERIOD 03/01/2020-02/28/2021 |
| Mod P00008· ADD SUBCONTRACTING PLAN | 2020-02-11 | +$0 | $925,721 | 2020 SUBCONTRACTING PLAN PERFORMANCE PERIOD 01/01/2020-12/31/2020 |
| Mod P00009· OTHER ADMINISTRATIVE ACTION | 2020-08-31 | +$0 | $925,721 | 2020 INVENTORY DUTIES 09/01/2020-02/28/2021 |
| Mod P00010· ADD SUBCONTRACTING PLAN | 2021-01-04 | +$0 | $925,721 | 2021 SUBCONTRACTING PLAN EFFECTIVE 01/01/2021-12/31/2021 |
| Mod P00011· EXERCISE AN OPTION | 2021-02-01 | +$0 | $925,721 | EXERCISE 4TH AND FINAL OPTION YEAR PERFORMANCE PERIOD 03/01/2021 - 02/28/2022 |
| Mod P00012· EXERCISE AN OPTION | 2021-12-13 | +$0 | $925,721 | EXTENDING THE 4TH OPTION YEAR SERVICES... PERFORMANCE PERIOD 03/01/2022 - 08/31/2022 |
| Mod P00013· ADD SUBCONTRACTING PLAN | 2022-01-12 | +$0 | $925,721 | 2022 SUBCONTRACTING PLAN EFFECTIVE 01/01/2022 - 12/31/2022 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI KE13UAQL1N24)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77026N0032 | NATIONAL CMOP OFFICE (36C770) · Q999 · MEDICAL- OTHER | $7,200,000 | FY2026 |
| 36C77026D0009 | NATIONAL CMOP OFFICE (36C770) · Q999 · MEDICAL- OTHER | $0 | FY2026 |
| 36E79725N0033 | NAC PHARMACEUTICALS (36E797) · Q999 · MEDICAL- OTHER | $270,899 | FY2025 |
| 36C77025K0073 | NATIONAL CMOP OFFICE (36C770) · Q999 · MEDICAL- OTHER | $219,077 | FY2025 |
| 36C77025K0061 | NATIONAL CMOP OFFICE (36C770) · Q999 · MEDICAL- OTHER | $307,076 | FY2025 |
| 36C77025K0074 | NATIONAL CMOP OFFICE (36C770) · Q999 · MEDICAL- OTHER | $425,910 | FY2025 |
Other recipients under 6505 from NAC PHARMACEUTICALS 36P797 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA797P17J0051 | MYLAN PHARMACEUTICALS INC | NAC PHARMACEUTICALS 36P797 | $17,881 | FY2017 |
| VA797P17J0052 | MYLAN PHARMACEUTICALS INC | NAC PHARMACEUTICALS 36P797 | $6,169 | FY2017 |
| VA797P17J0048 | KREMERS URBAN PHARMACEUTICALS INC. | NAC PHARMACEUTICALS 36P797 | $1,225,936 | FY2017 |
| VA797P17J0050 | MYLAN PHARMACEUTICALS INC | NAC PHARMACEUTICALS 36P797 | $72,904 | FY2017 |
| VA797P17J0053 | EXELAN PHARMACEUTICALS INC | NAC PHARMACEUTICALS 36P797 | $88,200 | FY2017 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA797P17C0025_3600 · retrieved 2026-09-26.